The genotypic inhibitory quotient: a predictive factor of atazanavir response in HIV-1-infected treatment-experienced patients.
Solas, Caroline
The genotypic inhibitory quotient: a predictive factor of atazanavir response in HIV-1-infected treatment-experienced patients. [electronic resource] - Journal of acquired immune deficiency syndromes (1999) Jun 2008 - 177-80 p. digital
Publication Type: Journal Article
1525-4135
10.1097/QAI.0b013e318164226a doi
Acquired Immunodeficiency Syndrome--drug therapy
Adult
Atazanavir Sulfate
CD4 Lymphocyte Count
Drug Resistance, Viral--genetics
Female
Genotype
HIV Protease Inhibitors--therapeutic use
HIV-1--drug effects
Humans
Male
Mutation
Oligopeptides--blood
Pyridines--blood
The genotypic inhibitory quotient: a predictive factor of atazanavir response in HIV-1-infected treatment-experienced patients. [electronic resource] - Journal of acquired immune deficiency syndromes (1999) Jun 2008 - 177-80 p. digital
Publication Type: Journal Article
1525-4135
10.1097/QAI.0b013e318164226a doi
Acquired Immunodeficiency Syndrome--drug therapy
Adult
Atazanavir Sulfate
CD4 Lymphocyte Count
Drug Resistance, Viral--genetics
Female
Genotype
HIV Protease Inhibitors--therapeutic use
HIV-1--drug effects
Humans
Male
Mutation
Oligopeptides--blood
Pyridines--blood